These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
199 related articles for article (PubMed ID: 11975978)
1. HLAMatchmaker: a molecularly based algorithm for histocompatibility determination. I. Description of the algorithm. Duquesnoy RJ Hum Immunol; 2002 May; 63(5):339-52. PubMed ID: 11975978 [TBL] [Abstract][Full Text] [Related]
2. HLAMatchmaker: a molecularly based algorithm for histocompatibility determination. II. Verification of the algorithm and determination of the relative immunogenicity of amino acid triplet-defined epitopes. Duquesnoy RJ; Marrari M Hum Immunol; 2002 May; 63(5):353-63. PubMed ID: 11975979 [TBL] [Abstract][Full Text] [Related]
3. HLAmatchmaker: a molecularly based algorithm for histocompatibility determination. III. Effect of matching at the HLA-A,B amino acid triplet level on kidney transplant survival. Duquesnoy RJ; Takemoto S; de Lange P; Doxiadis II; Schreuder GM; Persijn GG; Claas FH Transplantation; 2003 Mar; 75(6):884-9. PubMed ID: 12660519 [TBL] [Abstract][Full Text] [Related]
4. HLAmatchmaker: a molecularly based algorithm for histocompatibility determination. IV. An alternative strategy to increase the number of compatible donors for highly sensitized patients. Duquesnoy RJ; Howe J; Takemoto S Transplantation; 2003 Mar; 75(6):889-97. PubMed ID: 12660520 [TBL] [Abstract][Full Text] [Related]
5. HLAMatchmaker-based strategy to identify acceptable HLA class I mismatches for highly sensitized kidney transplant candidates. Duquesnoy RJ; Witvliet M; Doxiadis II; de Fijter H; Claas FH Transpl Int; 2004 Jan; 17(1):22-30. PubMed ID: 12955350 [TBL] [Abstract][Full Text] [Related]
6. The number of amino acid residues mismatches correlates with flow cytometry crossmatching results in high PRA renal patients. Lobashevsky AL; Senkbeil RW; Shoaf JL; Stephenson AK; Skelton SB; Burke RM; Deierhoi MH; Thomas JM Hum Immunol; 2002 May; 63(5):364-74. PubMed ID: 11975980 [TBL] [Abstract][Full Text] [Related]
7. HLAMatchmaker-driven analysis of responses to HLA-typed platelet transfusions in alloimmunized thrombocytopenic patients. Nambiar A; Duquesnoy RJ; Adams S; Zhao Y; Oblitas J; Leitman S; Stroncek D; Marincola F Blood; 2006 Feb; 107(4):1680-7. PubMed ID: 16269623 [TBL] [Abstract][Full Text] [Related]
8. Critical evaluation of the amino acid triplet-epitope matching concept in cadaver kidney transplantation. Laux G; Mytilineos J; Opelz G Transplantation; 2004 Mar; 77(6):902-7. PubMed ID: 15077035 [TBL] [Abstract][Full Text] [Related]
9. Utility of HLAMatchmaker and single-antigen HLA-antibody detection beads for identification of acceptable mismatches in highly sensitized patients awaiting kidney transplantation. Goodman RS; Taylor CJ; O'Rourke CM; Lynch A; Bradley JA; Key T Transplantation; 2006 May; 81(9):1331-6. PubMed ID: 16699463 [TBL] [Abstract][Full Text] [Related]
10. Clinical usefulness of HLAMatchmaker in HLA epitope matching for organ transplantation. Duquesnoy RJ Curr Opin Immunol; 2008 Oct; 20(5):594-601. PubMed ID: 18655832 [TBL] [Abstract][Full Text] [Related]
11. HLAMatchmaker-based definition of structural human leukocyte antigen epitopes detected by alloantibodies. Duquesnoy RJ; Marrari M Curr Opin Organ Transplant; 2009 Aug; 14(4):403-9. PubMed ID: 19417654 [TBL] [Abstract][Full Text] [Related]
12. A structurally based approach to determine HLA compatibility at the humoral immune level. Duquesnoy RJ Hum Immunol; 2006 Nov; 67(11):847-62. PubMed ID: 17145365 [TBL] [Abstract][Full Text] [Related]
13. Predicting the immunogenicity of human leukocyte antigen class I alloantigens using structural epitope analysis determined by HLAMatchmaker. Kosmoliaptsis V; Bradley JA; Sharples LD; Chaudhry A; Key T; Goodman RS; Taylor CJ Transplantation; 2008 Jun; 85(12):1817-25. PubMed ID: 18580476 [TBL] [Abstract][Full Text] [Related]
14. Correlations between Terasaki's HLA class I epitopes and HLAMatchmaker-defined eplets on HLA-A, -B and -C antigens. Duquesnoy RJ; Marrari M Tissue Antigens; 2009 Aug; 74(2):117-33. PubMed ID: 19497041 [TBL] [Abstract][Full Text] [Related]
15. Structural epitope matching for HLA-alloimmunized thrombocytopenic patients: a new strategy to provide more effective platelet transfusion support? Duquesnoy RJ Transfusion; 2008 Feb; 48(2):221-7. PubMed ID: 18005328 [TBL] [Abstract][Full Text] [Related]
16. HLAMatchmaker: a molecularly based algorithm for histocompatibility determination. V. Eplet matching for HLA-DR, HLA-DQ, and HLA-DP. Duquesnoy RJ; Askar M Hum Immunol; 2007 Jan; 68(1):12-25. PubMed ID: 17207708 [TBL] [Abstract][Full Text] [Related]
17. Differential immunogenicity of HLA mismatches in clinical transplantation. Claas FH; Dankers MK; Oudshoorn M; van Rood JJ; Mulder A; Roelen DL; Duquesnoy RJ; Doxiadis II Transpl Immunol; 2005 Aug; 14(3-4):187-91. PubMed ID: 15982562 [TBL] [Abstract][Full Text] [Related]
18. HLA matching at the epitope level: the way to go. Duquesnoy RJ Clin Transpl; 2013; ():441-51. PubMed ID: 25095540 [TBL] [Abstract][Full Text] [Related]
19. Major-histocompatibility-complex class I alleles and antigens in hematopoietic-cell transplantation. Petersdorf EW; Hansen JA; Martin PJ; Woolfrey A; Malkki M; Gooley T; Storer B; Mickelson E; Smith A; Anasetti C N Engl J Med; 2001 Dec; 345(25):1794-800. PubMed ID: 11752355 [TBL] [Abstract][Full Text] [Related]
20. Predicting HLA class I alloantigen immunogenicity from the number and physiochemical properties of amino acid polymorphisms. Kosmoliaptsis V; Chaudhry AN; Sharples LD; Halsall DJ; Dafforn TR; Bradley JA; Taylor CJ Transplantation; 2009 Sep; 88(6):791-8. PubMed ID: 19920778 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]